Huier Kangxin 3, a trivalent subunit influenza vaccine developed and produced by Ab&B Bio-Tech for the 2026-27 influenza season, was supplied in bulk for the first time and sent to vaccination sites in 14 provinces across China.

A groundbreaking ceremony for three new projects took place at the Port Industrial Park in the Taizhou Medical High-tech Zone, Taizhou, Jiangsu province, on Aug 5.

The Taizhou Medical High-tech Zone has been promoting the mechanization and intelligent construction of agricultural machinery.

In recent years, Baima town in Taizhou has vigorously revitalized idle factories and inefficient land use, achieving spatial reconstruction and industrial revitalization.

The national finals of the 2026 National Youth Vehicle Model Competition opened in Taizhou on July 18.

An oral phospholipid gel known as "Parishu", developed by Qianshan Medical Technology (Taizhou), has been approved for listing, bringing a new solution to cancer patients suffering from oral mucosal injury.

China has rolled out an action plan to better utilize foreign investment, with measures across five areas.

Jiangsu Realline Biotechnology, located in China Medical City, Taizhou, has been the guardian of equipment for local biopharmaceutical enterprises.